Security Snapshot

RESMED INC - Ordinary Shares (RMD) Institutional Ownership

CUSIP: 761152107

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

700

Shares (Excl. Options)

62.68MFull value: 62,684,918 · shares · 30 Sep 2026

Price

$221.10

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-3,928,574
Value change
-$847,363,269
Number of holders
700
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
145,199,667
SEC-reported price per share
$250.80
Insider filing price
$250.80
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • RMD - RESMED INC - Ordinary Shares is tracked under CUSIP 761152107.
  • 700 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 890 to 700 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $19.43BFull value: $19,427,211,076 · USD · 30 Jun 2026
    to
    $13.86BFull value: $13,860,841,546 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 700 institutions filings for Q3 2026.

Open SEC evidence

Security key

761152107

13F reference period

Q3 2026

13F holders

700

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
RMD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 8.2% $2,685,163,808 11,961,706 Vanguard Capital Management 31 Mar 2026
AustralianSuper Pty Ltd 5.7% $1,725,211,619 8,276,381 AustralianSuper Pty Ltd 30 Jun 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.4% $1,770,359,051 7,886,489 Vanguard Portfolio Management 31 Mar 2026
As of 30 Sep 2026, 700 institutional investors reported holding
62.68MFull value: 62,684,918 · shares · 30 Sep 2026
shares of RESMED INC - Ordinary Shares (RMD). This represents 43% of the company’s total
145.2MFull value: 145,199,667 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
29%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 9,446,041 0.04% $2,088,519,665
VANGUARD PORTFOLIO MANAGEMENT LLC 5.5% 7,923,806 0.08% $1,751,953,507
STATE STREET CORP 4.5% 6,519,249 0.04% $1,441,405,954
GEODE CAPITAL MANAGEMENT, LLC 3% 4,420,200 0.05% $973,889,075
Invesco Ltd. 1.2% 1,694,333 0.03% $374,616,941
NORDEA INVESTMENT MANAGEMENT AB 1% 1,458,663 0.26% $325,617,341
GOLDMAN SACHS GROUP INC 0.78% 1,137,492 0.03% $251,499,623
DIMENSIONAL FUND ADVISORS LP 0.78% 1,135,707 0.05% $251,120,390
Swedbank AB 0.67% 974,780 0.18% $215,523,858
Legal & General Group Plc 0.61% 881,030 0.04% $194,795,736
VANGUARD FIDUCIARY TRUST CO 0.56% 814,487 0.04% $180,083,076
Ilex Capital Partners (UK) LLP 0.51% 737,472 3.2% $163,055,059
BANK OF AMERICA CORP /DE/ 0.45% 654,211 0.01% $144,645,947
ALLIANCEBERNSTEIN L.P. 0.32% 469,375 0.03% $103,779,186
Quantinno Capital Management LP 0.3% 434,996 0.09% $96,177,817
Swiss National Bank 0.27% 394,480 0.05% $87,219,528
Giverny Capital Inc. 0.25% 369,970 2.8% $81,800,367
Caisse de depot et placement du Quebec 0.22% 324,997 0.11% $71,856,837
Vanguard Global Advisers, LLC 0.22% 317,992 0.03% $70,308,031
Welch & Forbes LLC 0.22% 314,911 0.83% $69,627,079
VANGUARD ASSET MANAGEMENT, Ltd 0.21% 303,329 0.04% $67,066,042
TWO SIGMA INVESTMENTS, LP 0.2% 295,657 0.05% $65,369,763
National Pension Service 0.19% 281,640 0.04% $62,270,604
Tandem Investment Advisors, Inc. 0.19% 270,856 4.3% $59,886,262
Nykredit A/S 0.18% 256,660 0.21% $56,747,526

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 62,684,918 $13,860,841,546 -$847,363,269 $221.10 700
2026 Q2 99,613,067 $19,427,211,076 +$380,975,396 $194.88 890
2026 Q1 97,269,539 $21,826,751,667 -$21,374,650 $224.48 941
2025 Q4 96,983,178 $23,361,931,740 +$1,010,595,349 $240.87 941
2025 Q3 91,805,254 $25,120,556,319 -$164,908,411 $273.73 939
2025 Q2 92,309,428 $23,802,163,537 -$234,889,533 $258.00 911
2025 Q1 93,341,270 $20,873,665,746 +$659,205,153 $223.85 872
2024 Q4 90,103,150 $20,611,027,939 +$523,118,005 $228.69 863
2024 Q3 86,823,807 $21,178,183,309 +$357,448,956 $244.12 792
2024 Q2 85,413,001 $16,344,246,847 +$454,535,216 $191.42 768
2024 Q1 82,914,769 $16,411,147,126 +$513,359,778 $198.03 710
2023 Q4 80,394,822 $13,829,283,421 -$1,271,808,453 $172.02 680
2023 Q3 87,735,817 $12,964,369,891 -$1,617,256,395 $147.87 648
2023 Q2 95,075,328 $20,771,183,152 -$111,688,592 $218.50 724
2023 Q1 95,323,306 $20,870,559,574 +$76,827,102 $218.99 665
2022 Q4 95,570,997 $19,893,153,622 -$213,631,417 $208.13 717
2022 Q3 96,528,325 $21,085,043,390 -$40,809,623 $218.30 650
2022 Q2 96,423,808 $20,247,886,410 -$216,827,167 $209.63 661
2022 Q1 97,272,612 $23,607,128,509 +$638,048,061 $242.51 658
2021 Q4 94,533,097 $24,611,319,237 -$550,619,558 $260.48 703
2021 Q3 96,265,199 $25,370,506,829 -$115,406,017 $263.55 673
2021 Q2 96,700,199 $23,835,730,320 -$548,687,648 $246.52 650
2021 Q1 99,033,646 $19,213,495,080 -$384,053,397 $194.02 649
2020 Q4 101,297,957 $21,523,684,165 +$125,179,911 $212.56 652
2020 Q3 100,513,676 $17,230,325,953 -$286,391,481 $171.43 612
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .